| Literature DB >> 27631781 |
Elena Pacella1, Daniele Mipatrini2, Fernanda Pacella1, Giulia Amorelli1, Andrea Bottone1, Gianpaolo Smaldone1, Paolo Turchetti3, Giuseppe La Torre2.
Abstract
BACKGROUND: Frontalis suspension surgery is considered the procedure of choice in cases of blepharoptosis. Among all the materials used in this type of surgery, ophthalmic and plastic surgeons prefer to use autologous Fascia Lata. However, during years, other autogenous and exogenous materials have been introduced.Entities:
Mesh:
Year: 2016 PMID: 27631781 PMCID: PMC5025102 DOI: 10.1371/journal.pone.0160827
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow chart of study selection.
Included studies.
| First author (year) | Design | N. of patients | N. of operations | Material | Quality |
|---|---|---|---|---|---|
| Shimizu (2015) [ | Cohort/Case series | 11 | 11 | Fascia Lata | 7 |
| Woo (2014) [ | Cohort/Case series | 82 | 101 | Fascia Lata | 6 |
| Suh (2013) [ | Cohort/Case series | 47 | 60 | Fascia Lata | 7 |
| Arajy (2012) [ | Cohort/Case series | 51 | 69 | Fascia Lata | 7 |
| Evereklioglu (2012)[ | Cohort/Case series | 18 | 26 | Fascia Lata | 6 |
| Sokol (2011) [ | Cohort/Case series | - | 156 | Fascia Lata | 6 |
| Bilgin (2010) [ | Cohort/Case series | 35 | 43 | Fascia Lata | 7 |
| Philandrianos (2010) [ | Cohort/Case series | 9 | 12 | Fascia Lata | 6 |
| Lee (2009) [ | Cohort/Case series | 63 | 91 | Fascia Lata | 6 |
| Yoon (2009) [ | Cohort/Case series | 239 | 324 | Fascia Lata | 8 |
| Cates (2008) [ | Cohort/Case series | 13 | 21 | Fascia Lata | 6 |
| Salour (2008) [ | Cohort/Case series | 10 | 15 | Fascia Lata | 6 |
| Bagheri (2007) [ | Cohort/Case series | 19 | 30 | Fascia Lata | 6 |
| DeMartelaere (2007) [ | Cohort/Case series | 25 | 48 | Fascia Lata | 6 |
| Leibovitch(2003) [ | Cohort/Case series | 9 | 14 | Fascia Lata | 6 |
| El-Toukhy (2001) [ | Cohort/Case series | 24 | 34 | Fascia Lata | 6 |
| Wesserman (2001) [ | Cohort/Case series | 43 | 102 | Fascia Lata | 6 |
| Khwarg (1999) [ | Cohort/Case series | 24 | 27 | Fascia Lata | 6 |
| Deenstra (1996) [ | Cohort/Case series | 81 | 81 | Fascia Lata | 6 |
| Chong (2010) [ | Cohort/Case series | 10 | 10 | Mersilene | 8 |
| Hafez (2008) [ | Cohort/Case series | 30 | 50 | Mersilene | 6 |
| Salour (2008) [ | Cohort/Case series | 10 | 16 | Mersilene | 6 |
| Mehta (2005) [ | Cohort/Case series | 20 | 32 | Mersilene | 6 |
| Sharma (2003) [ | Cohort/Case series | 41 | 71 | Mersilene | 7 |
| El-Toukhy (2001) [ | Cohort/Case series | 32 | 46 | Mersilene | 6 |
| Kemp (2001) [ | Cohort/Case series | 20 | 29 | Mersilene | 6 |
| Lam (1997) [ | Cohort/Case series | 10 | 10 | Mersilene | 5 |
| Can (1996) [ | Cohort/Case series | 22 | 23 | Mersilene | 6 |
| Gabrieli (1996) [ | Cohort/Case series | 14 | 20 | Mersilene | 6 |
| Hintschich (1995) [ | Cohort/Case series | 54 | 76 | Mersilene | 6 |
| Downes (1990) [ | Cohort/Case series | 15 | 23 | Mersilene | 5 |
| Hayashi (2013) [ | Cohort/Case series | 31 | 42 | PTFE | 8 |
| Nakauchi (2013) [ | Cohort/Case series | 20 | 27 | PTFE | 8 |
| Wei (2009) [ | Cohort/Case series | 96 | 130 | PTFE | 8 |
| Wesserman (2001) [ | Cohort/Case series | 43 | 102 | PTFE | 6 |
| Steinkogler (1993) [ | Cohort/Case series | 26 | 37 | PTFE | 6 |
| Bansal (2015) [ | Cohort/Case series | 25 | 38 | Silicon | 6 |
| Kim (2015) [ | Cohort/Case series | - | 98 | Silicon | 6 |
| Nucci (2015) [ | Cohort/Case series | 22 | 44 | Silicon | 6 |
| Razavi (2014) [ | Cohort/Case series | 44 | 70 | Silicon | 6 |
| Rizvi (2014) [ | Cohort/Case series | 46 | 56 | Silicon | 6 |
| Buttanri (2013) [ | Cohort/Case series | 56 | 80 | Silicon | 6 |
| Allen (2012) [ | Cohort/Case series | 31 | 62 | Silicon | 7 |
| Friedhofer (2012) [ | Cohort/Case series | 112 | 141 | Silicon | 6 |
| Van Sorge (2012) [ | Cohort/Case series | 69 | 101 | Silicon | 7 |
| Ali (2011) [ | Cohort/Case series | 33 | 35 | Silicon | 6 |
| Sokol (2011) [ | Cohort/Case series | - | 11 | Silicon | 6 |
| Lamont (2010) [ | Cohort/Case series | 26 | 42 | Silicon | 6 |
| Bernardini (2009) [ | Cohort/Case series | 10 | 16 | Silicon | 6 |
| Lee (2009) [ | Cohort/Case series | 60 | 90 | Silicon | 6 |
| Lelli (2009) [ | Cohort/Case series | 33 | 51 | Silicon | 7 |
| Fogagnolo (2008) [ | Cohort/Case series | 22 | 22 | Silicon | 6 |
| Carter (1996) [ | Cohort/Case series | 35 | 61 | Silicon | 6 |
Pooled percent prevalence of Successful Surgeries (SSs) and cumulative incidence of complications for each material considered.
CI = confidence interval.
| Fascia Lata | Mersilene | PTFE | Silicon | |
|---|---|---|---|---|
| % (95%CI) | % (95%CI) | % (95%CI) | % (95%CI) | |
| 87 (80–93) | 92 (87–96) | 99 (98–100) | 88 (83–91) | |
| 25 (14–39) | 17 (9–27) | 5 (0.6–13) | 15 (9–23) | |
| 1 (0.5–1.6) | 1.4 (0.4–3.0) | 1.9 (0.2–5.4) | 0.6 (0.2–1.2) | |
| 2.5 (0.7–5.3) | 3.6 (0.8–8.2) | 0.3 (0.0–1.2) | 2.2 (0.6–4.8) | |
| 2.1 (0.7–4.1) | 2.4 (0.7–5.1) | 1.5 (0.0–5.3) | 1.6 (0.4–3.5) | |
| 0.5 (0.2–0.9) | 2.3 (0.8–4.5) | 1.2 (0.0–3.7) | 1.0 (0.4–1.8) | |
| 0.4 (0.1–0.8) | 1.5 (0.5–3.1) | 0.5 (0.0–1.5) | 2.0 (1.0–3.4) | |
| 1.2 (0.4–2.7) | 1.0 (0.3–2.2) | 0.3 (0.0–1.2) | 0,7 (0.3–1.3) | |
| 0.8 (0.3–1.6) | - | - | - | |
| 0.3 (0.0–0.7) | 0.8 (0.0–1.8) | 0.3 (0.0–1.2) | 0.6 (0.2–1.2) | |
| 2.0 (0.8–3.6) | 0.7 (0.1–1.7) | 0.3 (0.0–1.2) | 0.5 (0.2–1.0) | |
| 0.4 (0.1–0.8) | 0.8 (0.2–1.9) | 0.3 (0.0–1.2) | 0.5 (0.2–1.1) | |
| 2.1 (0.0–7.3) | 0.7 (0.1–1.7) | 0.3 (0.0–1.2) | 0.4 (0.0–0.8) | |
| 1.2 (0.3–2.8) | 0.7 (0.1–1.7) | 0.3 (0.0–1.2) | 0.4 (0.0–0.8) | |
| 3.8 (1.5–7.3) | 3.2 (0.9–6.6) | 0.3 (0.0–1.2) | 3.0 (0.6–7.2) |
Meta-regression for the outcomes Succesfull Surgeries (SSs) and Overal Rate of Complications.
| β | P | β | P | β | P | |
| Year of publication | -0.10 | <0.1 | 1.06 | <0.01 | -0.60 | <0.01 |
| Mean age | -0.04 | 0.17 | 0.48 | <0.01 | -0.67 | <0.01 |
| Male proportion | -0.35 | <0.01 | -0.91 | <0.01 | -0.66 | <0.01 |
| Mean follow-up | 0.00 | 0.85 | 0.09 | 0.01 | 0.14 | 0.01 |
| Study quality | -0.29 | <0.01 | -0.18 | <0.01 | -0.06 | 0.46 |
| R2 | 0.24 | 0.63 | 0.35 | |||
| β | P | β | P | β | P | |
| Year of publication | 0.03 | 0.33 | 0.71 | <0.01 | -0.32 | <0.01 |
| Mean age | 0.04 | 0.12 | 0.37 | <0.01 | 0.09 | 0.24 |
| Male proportion | 0.25 | <0.01 | -0.17 | <0.01 | 0.27 | <0.01 |
| Mean follow-up | -0.10 | <0.01 | 0.14 | <0.01 | -0.42 | <0.01 |
| Study quality | -0.09 | <0.01 | -0.32 | <0.01 | 0.15 | 0.03 |
| 0.06 | 0.35 | 0.41 | ||||